Wellness Treatments Work—If You Test First

Why Baseline Testing Is the Foundation of Any Longevity Protocol

The wellness industry sells outcomes. Peptides, hormone replacement, nutraceuticals—all promise transformation. But transformation without a baseline is guesswork dressed as science.

I've reviewed hundreds of labs from patients who began peptide therapy, TRT, or complex supplement stacks without knowing their starting values. The result: confusion about what's working, delayed recognition of adverse changes, and missed opportunities to optimize dosing.

Here's the uncomfortable truth: your "normal" range on a lab report is not your optimal range, and your baseline is the only number that matters for measuring real progress.

What "Normal" Actually Means—And Why It Fails You

Laboratory reference ranges are population-derived statistics. They represent the 2.5th to 97.5th percentile of people who walked into a lab on a given day. That cohort is sick, healthy, sedentary, athletic, on medications, recovering from infection. It's a statistical spread, not a prescription.

When a lab says your testosterone is "within normal limits" at 380 ng/dL, they're saying you're not at the extreme low end of the population distribution. They're not saying you'll feel good, recover well, or build muscle at that level.

Your baseline is different. It's your neurological, metabolic, and hormonal set point before intervention. That's what you compare against.

The Essential Bloodwork Panel Before Peptides or Hormones

Growth Hormone Axis & IGF-1

• IGF-1 (fasting, early morning). Reference range is typically 84–237 ng/mL, but that's stratified by age. Your baseline IGF-1 predicts how your body will respond to GH secretagogues like GHRP-6, ipamorelin, or sermorelin. If baseline IGF-1 is <100, you likely have growth hormone deficit and will respond well. If it's already >180, aggressive GH stimulation risks pushing you into supraphysiologic territory.
• Fasting glucose. Not just for diabetes screening. Elevated baseline glucose (>110 fasting) signals insulin resistance, which blunts growth hormone secretion and IGF-1 responsiveness.

Testosterone & Estrogen

• Total testosterone, free testosterone (calculated or dialysis), SHBG. Men: reference >300 ng/dL total, but optimal is often 600–900 ng/dL for tissue responsiveness. Women: baseline total <70 ng/dL is typical.
• Estradiol. Sensitive assay (<10 pg/mL detection floor). In men using testosterone, estradiol creep is predictable; your baseline matters for aromatization rate prediction.

Thyroid

• TSH, free T3, free T4. TSH reference: 0.4–4.0 mIU/L. But optimal TSH for energy and metabolism is often 1.0–2.0. Baseline free T3 and T4 establish your thyroid reserve before peptide use (peptides can increase metabolic demand).

Metabolic & Stress

• Fasting insulin. <12 µIU/mL is reference; optimal is <5 µIU/mL. High baseline insulin signals metabolic resistance and poor peptide responsiveness.
• Cortisol (8 AM, saliva or serum). High baseline cortisol (usually >20 µg/dL at 8 AM) indicates chronic stress and will antagonize recovery and growth signaling from peptides.
• DHEA-S. Often overlooked. Low DHEA-S (<200 µg/dL in men, <150 in women) suggests adrenal exhaustion and poor HPA axis reserve.

Metabolic Health

• HbA1c, fasting glucose, lipid panel (total cholesterol, LDL, HDL, triglycerides). Baseline lipid dysfunction predicts cardiovascular risk intensification from hormone therapy.
• Liver function (AST, ALT, GGT), kidney function (creatinine, BUN, eGFR). Peptides and hormones are metabolized hepatically; baseline dysfunction requires dose adjustment or caution.
• CBC (complete blood count). Hemoglobin and hematocrit baseline; testosterone therapy raises RBC, and you need a safe starting point.

Micronutrient Status

• Magnesium (RBC magnesium, not serum—serum is poorly predictive). Optimal >5.5 mg/dL. Magnesium glycinate synergizes with peptides for recovery and sleep; deficiency blunts response.
• Zinc (serum zinc, also albumin since zinc binds albumin). Optimal 90–110 µg/dL. Critical for testosterone synthesis and IGF-1 receptor signaling.
• Vitamin D (25-hydroxyvitamin D3). Optimal >50 ng/mL. Low D3 (<30) impairs growth hormone secretion and testosterone bioavailability.
• B12 and folate. Methylated forms (methylcobalamin, methylfolate) work synergistically with peptides on neurological recovery. Baseline deficiency (<200 pg/mL B12, <2.7 ng/mL folate) needs repletion before therapy.

How to Use Your Baseline: The Strategy

1. Order comprehensive panel 2–4 weeks before starting peptides or hormones. Fasting, 8 AM blood draw (cortisol and testosterone have diurnal rhythm).
2. Request the actual values, not just "normal/abnormal" flags. You need numbers to track.
3. Retest 6–8 weeks after starting therapy. This interval captures IGF-1 response to GH secretagogues and hormonal adaptation.
4. Then retest every 12 weeks. Most people plateau in response after 4–6 months; testing frequency can drop if stable.
5. Map your supplement dosing to labs. If magnesium RBC is low, 400 mg glycinate daily. If zinc is <80, add 25 mg elemental zinc (with food, separate from iron). If D3 is <40, dose 4,000–5,000 IU daily until retest shows >50.

Bottom Line

Wellness treatments don't fail because the compounds are weak. They fail because people don't know their starting point and can't measure progress. Baseline bloodwork is not optional—it's the foundation of any protocol that claims to optimize your physiology. Test first. Dose second. Adjust by data, not hope.

Disclaimer: This content is for educational purposes only and does not constitute medical advice.